Event Date
Dr. Lei Stanley Qi is an Associate Professor of Bioengineering at Stanford University. He is a pioneer in the CRISPR technology and has played an integral role in the development of CRISPR tools that extend genome engineering beyond DNA editing. He invented the nuclease-dead dCas system and has led the development of CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), live-cell chromatin imaging, and 3D genome manipulation. His current research is centered on creating and utilizing tools to understand the function of epigenome and transcriptome in human cells and to enable better cell therapy for treating diseases. He received B.S. in Physics from Tsinghua University and Ph.D. in Bioengineering from the University of California, Berkeley, working with Dr. Adam Arkin and Dr. Jennifer Doudna. He was a Systems Biology Faculty Fellow at UCSF, prior to joining faculty at Stanford University in 2014. He is also an institute scholar at Sarafan ChEM-H at Stanford University and Chan Zuckerberg Biohub Investigator. Dr. Qi has won awards including the NIH Director's Early Independence Award, Pew Biomedical Scholar, Alfred P. Sloan Fellow, the NSF CAREER Award, Blavatnik Life Science Fellow, and the NIH Director's Pioneer Award.